P Nordmann
Overview
Explore the profile of P Nordmann including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
195
Citations
6654
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Catho G, Martischang R, Boroli F, Chraiti M, Martin Y, Koyluk Tomsuk Z, et al.
Crit Care
. 2021 Aug;
25(1):301.
PMID: 34412676
Background: Long-term outbreaks of multidrug-resistant Gram-negative bacilli related to hospital-building water systems have been described. However, successful mitigation strategies have rarely been reported. In particular, environmental disinfection or replacement of...
2.
Cebrero-Cangueiro T, Nordmann P, Carretero-Ledesma M, Pachon J, Pachon-Ibanez M
J Antimicrob Chemother
. 2020 Nov;
76(3):680-683.
PMID: 33227138
Objectives: To evaluate the in vivo efficacy of a dual carbapenem combination containing imipenem plus meropenem against carbapenem-resistant Acinetobacter baumannii producing carbapenemases OXA-23 or OXA-58. Methods: An experimental model of...
3.
Blanc D, Poncet F, Grandbastien B, Greub G, Senn L, Nordmann P
J Hosp Infect
. 2020 Oct;
108:19-24.
PMID: 33122041
Background: Extended-spectrum β-lactamase (ESBL)-producing Enterobacterales constitute a global burden for hospital infection, and the identification of carriers by screening patients at risk is recommended by several guidelines. Aim: To evaluate...
4.
Cheminet G, de Lastours V, Poirel L, Chau F, Peoch K, Massias L, et al.
J Antimicrob Chemother
. 2020 Aug;
75(12):3593-3600.
PMID: 32790873
Background: Carbapenemase-producing Enterobacterales represent a major therapeutic challenge. MBLs, requiring zinc at their catalytic site, could be inhibited by meso-dimercaptosuccinic acid (DMSA), a heavy metal chelator already widely used for...
5.
Masseron A, Poirel L, Jamil Ali B, Syed M, Nordmann P
New Microbes New Infect
. 2019 Nov;
32:100605.
PMID: 31709068
Extended-spectrum β-lactamases, carbapenemases, 16S rRNA methylases conferring pan-drug aminoglycoside resistance and colistin resistance were investigated among Gram-negative bacteria recovered from clinical samples (infections) from 200 individuals hospitalized at the Khyber...
6.
Fantin B, Poujade J, Gregoire N, Chau F, Roujansky A, Kieffer N, et al.
Clin Microbiol Infect
. 2019 Sep;
25(12):1563.e5-1563.e8.
PMID: 31494253
Objectives: Colistin often remains the last resort antibiotic active against carbapenemase-producing Enterobacteriaceae. However, while in vitro inoculum effect has been reported, therapeutic relevance of this phenomenon remains questioned. Methods: Ten...
7.
Alvarez-Marin R, Aires-de-Sousa M, Nordmann P, Kieffer N, Poirel L
Eur J Clin Microbiol Infect Dis
. 2017 Aug;
36(12):2379-2383.
PMID: 28825186
Multidrug-resistant (MR) Gram-negative (GN) pathogens pose a major and growing threat for healthcare systems, as therapy of infections is often limited due to the lack of available systemic antibiotics. Well-tolerated...
8.
Dobias J, Denervaud-Tendon V, Poirel L, Nordmann P
Eur J Clin Microbiol Infect Dis
. 2017 Jul;
36(12):2319-2327.
PMID: 28748397
The novel siderophore cephalosporin cefiderocol (S-649266) with potent activity against Gram-negative pathogens was recently developed (Shionogi & Co., Ltd.). Here, we evaluated the activity of this new molecule and comparators...
9.
Jayol A, Nordmann P, Lehours P, Poirel L, Dubois V
Clin Microbiol Infect
. 2017 Jun;
24(2):175-179.
PMID: 28606644
Objectives: Because of the emergence of plasmid-mediated (mcr-1 and mcr-2 genes) and chromosomally encoded colistin resistance, reliable methods for detecting colistin resistance/susceptibility in routine laboratories are required. We evaluated the...
10.
Dobias J, Poirel L, Nordmann P
Clin Microbiol Infect
. 2017 Mar;
23(9):676.e1-676.e5.
PMID: 28344161
Objectives: To evaluate whether acquired resistance to cationic antimicrobial peptide (CAMP) group molecules, being normal components of the human immune system, may select co-resistance to antibiotic peptides such as polymyxins,...